Back to the main directory
Press Release
- Outbrain announces repurchase of remaining 2.95% Convertible Senior Notes due 2026 by GlobeNewsWire
- Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations by GlobeNewsWire
- Troilus Announces Enhanced Renewable Energy Capacity at the Troilus Site by GlobeNewsWire
- Opthea Joins the S&P/ASX 300 Index by GlobeNewsWire
- Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024) by GlobeNewsWire
- Skye Bioscience Comments on Monlunabant Phase 2 Top-line Data and Reiterates Confidence in Nimacimab Clinical Development Plan by GlobeNewsWire
- EQS-News: ARTCLINE appoints Dirk Hessel as Managing Director and Prepares the Market Entry for Innovative Septic Shock Treatment by EQS Group AG
- Ivanhoe Electric's VRB Energy Subsidiary Secures $55 Million Investment by Newsfile Corp.
- uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease by GlobeNewsWire
- EQS-News: Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024 by EQS Group AG
- ServiceNow Demonstrates Commitment to Building a Better World, Expands Access to Technology, Knowledge, and Opportunity by BusinessWire
- Dividend Declaration by GlobeNewsWire
- Le médicament Kayfanda® (odévixibat) d’Ipsen est approuvé dans l’Union européenne pour le prurit cholestatique lié au syndrome d’Alagille, une maladie hépatique rare by GlobeNewsWire
- Placements AGF annonce les distributions en espèces de septembre 2024 pour certains FNB AGF et fonds de série FNB AGF by GlobeNewsWire
- Avicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.ca by GlobeNewsWire
- Stardust Power Welcomes Paramita Das as Chief Strategy Officer and Senior Advisor to Chief Executive by GlobeNewsWire
- BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody by GlobeNewsWire
- IDEX Biometrics extraordinary general meeting held on 23 Sep 2024 by GlobeNewsWire
- Jeffs’ Brands: Fort Products Recognized by Amazon UK as a Key Account, Eligible for the Top Seller Program by GlobeNewsWire
- Sports.com Expands Geographical Footprint, Launching in New Markets Across Asia by GlobeNewsWire
- Schouw & Co. aktietilbagekøbsprogram, uge 38 2024 by GlobeNewsWire
- Novo Nordisk A/S - share repurchase programme by GlobeNewsWire
- Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer by GlobeNewsWire
- New Family of Voltage-Controlled Saw Oscillators with Ultra-Low Phase Noise Performance for Radar Applications by GlobeNewsWire
- Kratos SRE Welcomes Congressman Gary Palmer to Facility in Birmingham by GlobeNewsWire